Handelsbanken Fonder AB Sells 800 Shares of HealthEquity, Inc. $HQY

Handelsbanken Fonder AB lessened its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 3.6% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 21,516 shares of the company’s stock after selling 800 shares during the period. Handelsbanken Fonder AB’s holdings in HealthEquity were worth $2,254,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of HQY. Dynamic Technology Lab Private Ltd purchased a new position in HealthEquity in the second quarter worth $2,882,000. Westfield Capital Management Co. LP boosted its holdings in shares of HealthEquity by 124.6% in the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock worth $132,543,000 after buying an additional 701,819 shares during the last quarter. GDS Wealth Management boosted its holdings in shares of HealthEquity by 28.4% in the 2nd quarter. GDS Wealth Management now owns 87,287 shares of the company’s stock worth $9,144,000 after buying an additional 19,280 shares during the last quarter. Artisan Partners Limited Partnership grew its position in HealthEquity by 44.8% during the second quarter. Artisan Partners Limited Partnership now owns 621,647 shares of the company’s stock valued at $65,124,000 after buying an additional 192,252 shares during the period. Finally, Renaissance Group LLC increased its holdings in HealthEquity by 30.2% during the second quarter. Renaissance Group LLC now owns 73,955 shares of the company’s stock worth $7,748,000 after buying an additional 17,144 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, EVP Delano Ladd sold 1,500 shares of the stock in a transaction dated Thursday, November 20th. The shares were sold at an average price of $104.56, for a total value of $156,840.00. Following the sale, the executive vice president directly owned 75,479 shares of the company’s stock, valued at approximately $7,892,084.24. This represents a 1.95% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Michael Henry Fiore sold 1,781 shares of the business’s stock in a transaction that occurred on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the transaction, the executive vice president directly owned 49,795 shares of the company’s stock, valued at approximately $4,392,416.95. This represents a 3.45% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 10,781 shares of company stock worth $1,016,707. Company insiders own 1.50% of the company’s stock.

HealthEquity Trading Up 1.7%

NASDAQ:HQY opened at $105.44 on Wednesday. HealthEquity, Inc. has a 1 year low of $74.07 and a 1 year high of $116.65. The stock’s fifty day moving average price is $95.45 and its two-hundred day moving average price is $96.67. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23. The company has a market cap of $9.08 billion, a P/E ratio of 63.90, a P/E/G ratio of 1.36 and a beta of 0.47.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, September 2nd. The company reported $0.92 earnings per share for the quarter, meeting the consensus estimate of $0.92. The company had revenue of $325.80 million during the quarter, compared to analysts’ expectations of $320.68 million. HealthEquity had a return on equity of 12.04% and a net margin of 11.49%. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. As a group, analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have recently weighed in on HQY shares. Wall Street Zen downgraded shares of HealthEquity from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. BMO Capital Markets assumed coverage on HealthEquity in a research note on Thursday, November 13th. They issued a “market perform” rating and a $100.00 price objective on the stock. KeyCorp reduced their price objective on HealthEquity from $125.00 to $120.00 and set an “overweight” rating for the company in a report on Wednesday, October 8th. JPMorgan Chase & Co. boosted their target price on HealthEquity from $125.00 to $126.00 and gave the company an “overweight” rating in a research note on Wednesday, September 3rd. Finally, Royal Bank Of Canada upped their price target on HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, September 3rd. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $119.00.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.